Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Researchers at Roche present novel A-FABP inhibitors

Oct. 15, 2014

Merck Sharp & Dohme designs new tyrosine-protein kinase inhibitors

Oct. 15, 2014

Researchers at Merck & Co. disclose new agents for Alzheimer's disease

Oct. 15, 2014

A team of scientists at Amgen synthesizes novel protease inhibitors

Oct. 15, 2014

Novel 5-bromo-indirubins disclosed for non-small cell lung cancer

Oct. 14, 2014

Novel viral entry inhibitors synthesized for DENV infection

Oct. 13, 2014

Merck & Co. divulges new JAK inhibitors

Oct. 13, 2014

Chinese group patents new ALK inhibitors for cancer

Oct. 13, 2014

Researchers at Edison Pharmaceuticals disclose new agents for Friedreich's ataxia

Oct. 13, 2014

New aldehyde compounds disclosed for sickle cell disease and other disorders

Oct. 13, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...